It is believed that Th1 cells promote CD8+ T cell immunity to tumor cells as well as enhance anti-tumor immune responses by recruiting inflammatory cells, such as macrophages, granulocytes, and NK cells, to the site of tumor tissue. This evidence concerns the gene CD8A and neoplasm.